Literature DB >> 19856436

Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?

Utaroh Motosugi1, Tomoaki Ichikawa, Hironobu Sou, Katsuhiro Sano, Licht Tominaga, Takatoshi Kitamura, Tsutomu Araki.   

Abstract

PURPOSE: To clarify the factors that predict enhancement of the liver parenchyma in hepatocyte-phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging.
MATERIALS AND METHODS: Gd-EOB-DTPA-enhanced hepatocyte-phase MR images of 198 patients with chronic liver diseases (Child-Pugh class A in 112 patients, class B in 74 patients, and class C in 12 patients) were retrospectively analyzed. The hepatocyte-phase images were obtained using fat-suppressed T1-weighted gradient-echo images with a 3D acquisition sequence 10 min and 20 min after IV administration of Gd-EOB-DTPA (0.025 mmol/kg body weight). The quantitative liver-spleen contrast ratio (Q-LSC) was calculated using the signal intensities of the liver and spleen. Serum albumin levels, total bilirubin levels, prothrombin activity, and the results of indocyanine green clearance tests (ICGs) were recorded and correlated with the Q-LSC. Logistic regression analysis was performed to analyze which factors predict sufficient liver enhancement using a Q-LSC of 1.5 as a cutoff value.
RESULTS: Only ICGs and Child-Pugh classifications showed a statistically significant correlation with the Q-LSC. Logistic regression analysis showed that ICGs were the only factors that accurately predicted liver enhancement on hepatocyte-phase images.
CONCLUSION: ICGs were found to be predictors of sufficient liver enhancement on hepatocyte-phase images.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19856436     DOI: 10.1002/jmri.21956

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  82 in total

1.  Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

Authors:  Shinichi Nakamura; Kazuo Awai; Daisuke Utsunomiya; Tomohiro Namimoto; Takeshi Nakaura; Kosuke Morita; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

2.  Gd-BOPTA-enhanced MR cholangiography findings in gall bladder perforation.

Authors:  Oktay Algin; Nuraydin Ozlem; Evrim Kilic; Mustafa Karaoglanoglu; Halil Arslan
Journal:  Emerg Radiol       Date:  2010-06-29

3.  Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI.

Authors:  H Rhee; M-J Kim; M-S Park; K A Kim
Journal:  Br J Radiol       Date:  2012-05-02       Impact factor: 3.039

4.  Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid.

Authors:  Jordi Rimola; Anna Darnell; Ernest Belmonte; Victor Sapena; Carla Caparroz; Neus Llarch; Maria Reig; Alejandro Forner; Jordi Bruix; Carmen Ayuso
Journal:  Eur Radiol       Date:  2020-06-30       Impact factor: 5.315

5.  The inhibitory effect of gadoxetate disodium on hepatic transporters: a study using indocyanine green.

Authors:  Hiroyuki Akai; Koichiro Yasaka; Akira Kunimatsu; Masanori Nojima; Yusuke Inoue; Osamu Abe; Kuni Ohtomo; Shigeru Kiryu
Journal:  Eur Radiol       Date:  2018-04-12       Impact factor: 5.315

6.  Increase in left liver lobe function after preoperative right portal vein embolisation assessed with gadolinium-EOB-DTPA MRI.

Authors:  Dominik Geisel; Lutz Lüdemann; Thomas Keuchel; Maciej Malinowski; Daniel Seehofer; Martin Stockmann; Bernd Hamm; Bernhard Gebauer; Timm Denecke
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

7.  The expression of transporter OATP2/OATP8 decreases in undetectable hepatocellular carcinoma by Gd-EOB-MRI in the explanted cirrhotic liver.

Authors:  Masaaki Hidaka; Mitsuhisa Takatsuki; Sadayuki Okudaira; Akihiko Soyama; Izumi Muraoka; Takayuki Tanaka; Izumi Yamaguchi; Takanobu Hara; Hisamitsu Miyaaki; Tatsuki Ichikawa; Tomayoshi Hayashi; Ichiro Sakamoto; Kazuhiko Nakao; Tamotsu Kuroki; Takashi Kanematsu; Susumu Eguchi
Journal:  Hepatol Int       Date:  2012-06-24       Impact factor: 6.047

8.  Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Authors:  Kazuto Kozaka; Satoshi Kobayashi; Norihide Yoneda; Azusa Kitao; Kotaro Yoshida; Dai Inoue; Takahiro Ogi; Wataru Koda; Yasunori Sato; Toshifumi Gabata; Osamu Matsui
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

Review 9.  Insight into hepatocellular carcinoma biology with gadoxetate disodium-enhanced MRI.

Authors:  Alexander Kagen; Kathryn Fowler; Claude B Sirlin
Journal:  Hepat Oncol       Date:  2013-12-20

10.  Diffusion kurtosis imaging in the assessment of liver function: Its potential as an effective predictor of liver function.

Authors:  Daisuke Yoshimaru; Yasuo Takatsu; Yuichi Suzuki; Toshiaki Miyati; Yuhki Hamada; Ayumu Funaki; Ayumi Tabata; Chifumi Maruyama; Masahiko Shimada; Maki Tobari; Takayoshi Nishino
Journal:  Br J Radiol       Date:  2018-11-01       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.